We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current XLO market cap is 34.81M. The company's latest EPS is USD -1.7383 and P/E is -0.45.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -23.53M | -20.12M | -17.36M | -18.13M | -17.49M |
| Net Income | -22.65M | -19.36M | -16.75M | -17.66M | -17.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -19.03M | -54.56M | -75.04M | -89.15M | -79.13M |
| Net Income | -17.31M | -55.22M | -75.8M | -88.22M | -76.4M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 111.51M | 92.36M | 77.84M | 60.93M | 82.61M |
| Total Liabilities | 26.71M | 24.98M | 25.34M | 24.1M | 56.84M |
| Total Equity | 84.79M | 67.38M | 52.5M | 36.83M | 25.77M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 62.72M | 36.32M | 218.06M | 139.17M | 60.93M |
| Total Liabilities | 24.21M | 41.6M | 32.63M | 33.52M | 24.1M |
| Total Equity | -29.52M | -83.29M | 185.43M | 105.65M | 36.83M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -25.25M | -41.82M | -55.19M | -68.62M | -10.5M |
| Investing | -170k | -486k | -486k | -486k | N/A |
| Financing | -1.69M | -2.68M | -4.92M | -6.55M | 954k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.84M | -36.09M | -80.75M | -75.72M | -68.62M |
| Investing | -715k | -2.19M | -1.1M | -1.87M | -486k |
| Financing | 60.02M | 10.03M | 260.67M | -69k | -6.55M |
| Market Cap | 34.81M |
| Price to Earnings Ratio | -0.45 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.77 |
| Price to Book Ratio | 0.93 |
| Dividend Yield | - |
| Shares Outstanding | 43.95M |
| Average Volume (1 week) | 117.92k |
| Average Volume (1 Month) | 197.56k |
| 52 Week Change | -60.80% |
| 52 Week High | 2.8938 |
| 52 Week Low | 0.49 |
| Spread (Intraday) | 0.08 (9.63%) |
| Company Name | Xilio Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://xiliotx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
